Channels - Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective :: FRELIP Discovery

Similar Items: Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective

Quick Look
Mapping Digital Nudges and Recommender Systems for Obesity Prevention: Scoping Review
Quick Look
Impact of the Online Nutrition Intervention on Health Indicators for Diabetes, Cardiovascular Disease, and Obesity in Senior Populations
Quick Look
Public Health Impact and Cost-Effectiveness of 2-Dose vs 1-Dose Human Papillomavirus Vaccination Regimen in Saudi Arabia
Quick Look
A Systematic-Narrative Review of Digital Interventions Preventing Childhood Obesity Among Culturally Diverse Families
Quick Look
Healthcare Resource Utilization and the Direct Medical Cost of Fibromyalgia Patients in a Tertiary Hospital in Saudi Arabia
Quick Look
Cost Impact of a Novel Pre-transplant Risk Assessment Tool for Early Acute Rejection in Kidney Transplant Patients
Quick Look
Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa
Quick Look
Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experience
Quick Look
A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in Spain
Quick Look
Social Impact and Economic Burden of Uncoded Hyponatremia in Elderly – A Cost-of-Illness Study
Quick Look
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
Quick Look
Cost-Effectiveness and Clinical Utility of Pancreatic Cancer Non-Invasive Test in New-Onset Diabetes
Quick Look
Discounting Practices in Cost-Effectiveness Analyses in Dentistry: A Systematic Review of Studies Published After 2020
Quick Look
Cost-Effectiveness of Chondroitin Sulphate (with or without Glucosamine) Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs
Quick Look
Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case–Control Study
Quick Look
Activity-Based Costing of COVID-19 RT-PCR Testing in Public Laboratories in Indonesia: Evidence for Tariff Setting
Quick Look
Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy
Quick Look
Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy
Quick Look
The New England 4G framework for the treatment of a common health concerns: a gambling case analysis
Quick Look
Estimated Cost of Adverse Event Management in Treatment Naïve Non-small Cell Lung Cancer Patients with Common EGFR Mutations Treated with Amivantamab Plus Lazertinib and Osimertinib Plus Chemotherapy
Quick Look
Healthcare Utilization and Costs After Appropriate or Inappropriate Implantable Defibrillator Shocks: A Retrospective Real-World Data Study in Japan
Quick Look
Dynamical behavior analysis of 2-control strategies on tuberculosis model
Quick Look
A Comparative Study of MR‐Guided Needle Insertion for Surgical Procedures: Insights From HoloLens 2, Magic Leap 2 and Apple Vision Pro
Quick Look
Implementation of Primary Care Based Chronic Disease Management Programs for Hypertensive and Type 2 Diabetes Mellitus Patients: A Scoping Review